Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


A novel role for Lyl1 in primitive erythropoiesis.

Chiu SK, Saw J, Huang Y, Sonderegger SE, Wong NC, Powell DR, Beck D, Pimanda JE, Tremblay CS, Curtis DJ.

Development. 2018 Oct 11;145(19). pii: dev162990. doi: 10.1242/dev.162990.


Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.

Souroullas GP, Salmon JM, Sablitzky F, Curtis DJ, Goodell MA.

Cell Stem Cell. 2009 Feb 6;4(2):180-6. doi: 10.1016/j.stem.2009.01.001.


Impaired in vitro erythropoiesis following deletion of the Scl (Tal1) +40 enhancer is largely compensated for in vivo despite a significant reduction in expression.

Ferreira R, Spensberger D, Silber Y, Dimond A, Li J, Green AR, Göttgens B.

Mol Cell Biol. 2013 Mar;33(6):1254-66. doi: 10.1128/MCB.01525-12. Epub 2013 Jan 14.


The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl-/- phenotype.

Chan WY, Follows GA, Lacaud G, Pimanda JE, Landry JR, Kinston S, Knezevic K, Piltz S, Donaldson IJ, Gambardella L, Sablitzky F, Green AR, Kouskoff V, Göttgens B.

Blood. 2007 Mar 1;109(5):1908-16. Epub 2006 Oct 19.


Combinatorial regulation of novel erythroid gene expression in zebrafish.

Galloway JL, Wingert RA, Thisse C, Thisse B, Zon LI.

Exp Hematol. 2008 Apr;36(4):424-32. doi: 10.1016/j.exphem.2007.11.015. Epub 2008 Feb 4.


Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.

Gering M, Yamada Y, Rabbitts TH, Patient RK.

Development. 2003 Dec;130(25):6187-99. Epub 2003 Nov 5.


Primitive erythropoiesis in the mammalian embryo.

Palis J, Malik J, McGrath KE, Kingsley PD.

Int J Dev Biol. 2010;54(6-7):1011-8. doi: 10.1387/ijdb.093056jp. Review.


Ldb1 complexes: the new master regulators of erythroid gene transcription.

Love PE, Warzecha C, Li L.

Trends Genet. 2014 Jan;30(1):1-9. doi: 10.1016/j.tig.2013.10.001. Epub 2013 Nov 27. Review.


Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.

McCormack MP, Shields BJ, Jackson JT, Nasa C, Shi W, Slater NJ, Tremblay CS, Rabbitts TH, Curtis DJ.

Blood. 2013 Sep 19;122(12):2093-103. doi: 10.1182/blood-2012-09-458570. Epub 2013 Aug 7.


Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Kassouf MT, Hughes JR, Taylor S, McGowan SJ, Soneji S, Green AL, Vyas P, Porcher C.

Genome Res. 2010 Aug;20(8):1064-83. doi: 10.1101/gr.104935.110. Epub 2010 Jun 21.


SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.

Hoang T, Lambert JA, Martin R.

Curr Top Dev Biol. 2016;118:163-204. doi: 10.1016/bs.ctdb.2016.01.004. Epub 2016 Feb 18. Review.


T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Rogers H, Wang L, Yu X, Alnaeeli M, Cui K, Zhao K, Bieker JJ, Prchal J, Huang S, Weksler B, Noguchi CT.

J Biol Chem. 2012 Oct 26;287(44):36720-31. doi: 10.1074/jbc.M112.378398. Epub 2012 Sep 16.


Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq.

Tallack MR, Magor GW, Dartigues B, Sun L, Huang S, Fittock JM, Fry SV, Glazov EA, Bailey TL, Perkins AC.

Genome Res. 2012 Dec;22(12):2385-98. doi: 10.1101/gr.135707.111. Epub 2012 Jul 26.


Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.

Nagel S, Venturini L, Meyer C, Kaufmann M, Scherr M, Drexler HG, MacLeod RA.

Leuk Res. 2010 Apr;34(4):521-8. doi: 10.1016/j.leukres.2009.06.020. Epub 2009 Jul 15.


Lyl1 interacts with CREB1 and alters expression of CREB1 target genes.

San-Marina S, Han Y, Suarez Saiz F, Trus MR, Minden MD.

Biochim Biophys Acta. 2008 Mar;1783(3):503-17. Epub 2007 Dec 7.


Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.

San-Marina S, Han Y, Liu J, Minden MD.

Biochim Biophys Acta. 2012 Nov-Dec;1819(11-12):1164-72. doi: 10.1016/j.bbagrm.2012.09.004. Epub 2012 Sep 19.


Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.

Deleuze V, El-Hajj R, Chalhoub E, Dohet C, Pinet V, Couttet P, Mathieu D.

PLoS One. 2012;7(7):e40484. doi: 10.1371/journal.pone.0040484. Epub 2012 Jul 6.


The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.

Ogilvy S, Ferreira R, Piltz SG, Bowen JM, Göttgens B, Green AR.

Mol Cell Biol. 2007 Oct;27(20):7206-19. Epub 2007 Aug 20.


Interaction of retinoic acid and scl controls primitive blood development.

de Jong JL, Davidson AJ, Wang Y, Palis J, Opara P, Pugach E, Daley GQ, Zon LI.

Blood. 2010 Jul 15;116(2):201-9. doi: 10.1182/blood-2009-10-249557. Epub 2010 Apr 21.

Supplemental Content

Support Center